Gain valuable insights from The Tisch Cancer Institute at Mount Sinai—a National Cancer Institute-designated cancer center—and cancer specialists throughout the Mount Sinai Health System. Our extensive network spans cancer prevention, innovative developments in precision-medicine treatment including immunotherapy approaches, novel clinical trials, and groundbreaking translational research.
Under the leadership of Ramon Parsons, MD, PhD, Joseph A. Sparano, MD, and Luis Isola, MD, our comprehensive cancer program is renowned for its powerful synergy between research scientists and clinicians and its multidisciplinary scope, and is nationally ranked by U.S. News & World Report.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Gain valuable insights from The Tisch Cancer Institute at Mount Sinai—a National Cancer Institute-designated cancer center—and cancer specialists throughout the Mount Sinai Health System. Our extensive network spans cancer prevention, innovative developments in precision-medicine treatment including immunotherapy approaches, novel clinical trials, and groundbreaking translational research.
Under the leadership of Ramon Parsons, MD, PhD, Joseph A. Sparano, MD, and Luis Isola, MD, our comprehensive cancer program is renowned for its powerful synergy between research scientists and clinicians and its multidisciplinary scope, and is nationally ranked by U.S. News & World Report.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Latest Videos
Video
Ramon Parsons, MD, PhD, explains PTEN and cancer
A Department of Medicine Grand Rounds presented by Ramon Parsons, MD, PhD, Director, The Tisch Cancer Institute, and Chair of Oncological Sciences at the Icahn School of Medicine at Mount Sinai
Video
Luis M. Isola, MD, discusses fighting hematological cancers
A profile of Luis M. Isola, MD, Director of Cancer Clinical Programs, Mount Sinai Health System
Video
Steven J. Burakoff, MD, looks to the future of cancer care
A profile of Steven J. Burakoff, MD, Dean for Cancer Innovation at the Icahn School of Medicine at Mount Sinai and Chief of Pediatric Oncology at the Mount Sinai Health System
News
Internationally Renowned Breast Cancer and HIV-Associated Malignancy Expert to Join Mount Sinai
News
Immune cells that normally repair tissues in the body can be fooled by tumors when cancer starts forming in the lungs and instead help the tumor become invasive, according to a surprising discovery reported by Mount Sinai scientists in Nature.
Video
Bladder Cancer Treatment Without Cystectomy
Matthew Galsky, MD, reported at the 2021 ASCO annual meeting that transurethral resection of bladder tumor + gemcitabine, cisplatin, plus nivolumab achieves stringently defined clinical complete response in a large subset of patients with ...
News
Anti-HER2 Treatments Can Cause Pulmonary Toxicities in HER2+ Breast Cancer
Charles Powell, MD, System Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine and CEO of the Mount Sinai-National Jewish Health Respiratory Institute, answers questions regarding anti-HER2 monoclonal ...
News
Dr. Matthew Galsky and colleagues identify genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder
Document
NYEE’s Ocular Oncology Service Expanded Patient Options for Eye Cancer Treatment
The Ocular Oncology Service at NYEE is home to the most advanced forms of eye cancer treatments aimed at preserving life, preserving the eye, and saving sight
News
A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers.
News
The Tisch Cancer Institute Specialty Report 2021
Message from the Director of The Tisch Cancer Institute
Video
What’s New in Gynecologic Cancer Treatment?
Experts from The Blavatnik Family – Chelsea Medical Center at Mount Sinai discuss the capabilities and interdisciplinary approach at the Center
News
Deirdre J. Cohen, MD, MS, an expert in pancreatic and other gastrointestinal cancers, has joined Mount Sinai Health System as Director of the Gastrointestinal Oncology Program
News
The Tisch Cancer Institute Earns Second Consecutive Designation From National Cancer Institute
The Tisch Cancer Institute at Mount Sinai has been awarded $13 million as part of the renewal of its National Cancer Institute Cancer Center Designation
Document
The results of this Phase 1 study support the use of rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia
Video
Safety Protocols In The Department of Surgery
Benjamin J. Golas, MD, Chief of Surgical Oncology, reviews the practices in place to ensure patient safety.
Video
Should Patients Wait To Receive Cancer Treatment?
Benjamin J. Golas, MD, discusses why patients shouldn’t wait to seek treatment for cancer during the COVID-19 pandemic.
Video
Can Patients Receive Cancer Surgery in the COVID-19 Era?
With the approval of New York State, surgeries have recommenced. Benjamin J. Golas, MD, discusses the special precautions for cancer patients scheduled for surgery.
Video
Telemedicine As An Option for Cancer Treatment
Benjamin J. Golas, MD, Chief of Surgical Oncology, discusses the role of telemedicine in treating cancer patients.
Video
Liver Lessons and Liquid Biopsies
Augusto Rodriguez, MD, PhD, discusses a novel technology to detect liver cancer—liquid biopsy—as well as an overview of liver cancer’s causes, diagnosis, and treatment.
News
2020 Specialty Report: The Tisch Cancer Institute
Learn about the groundbreaking work conducted at The Tisch Cancer Institute at Mount Sinai.
Video
What to Know About Skin Cancer During COVID-19
Andrew Alexis, MD, MPH, discusses the basics of skin cancer and getting care during COVID-19.
Video
COVID-19: Impact on Melanoma Patients
What melanoma patients can expect from their telemedicine appointment during COVID-19.
Video
Adilia Hormigo, MD, PhD, Discusses Research on Treating Glioblastoma
Clinical trial uses laser interstitial thermal therapy and avelumab for glioblastoma.
Video
Treating Myeloma During the COVID-19 Crisis
Joshua Richter, MD, provides guidance on multiple myeloma treatment during COVID-19.
Video
Cancer Prevention and Control: HPV, Oropharyngeal Cancer, and Cervical Cancer
Gain insights on the latest research and treatment strategies.
News
COVID-19 and What Multiple Myeloma Patients Need to Know
Treating Multiple Myeloma in the Midst of COVID-19
Video
COVID-19: What Cancer Patients Need to Know
Cardinale B. Smith, MD, PhD, provides advice, tips, and information about COVID-19, specific to needs of cancer patients
Video
Is the Gleason Grading Still Relevant With Respect to Outcome?
Gleason grading system is important prognostic factor for prostate cancer.
Video
Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers
A simple blood test can predict outcomes after hematopoietic cell transplants
Video
Are we Ready to De-escalate Treatment of HPV+ Head & Neck Cancer?
Changing paradigms for treating HPV+ head & neck cancer
News
Mapping Multiple Myeloma Advances in NYC
Hear experts from Mount Sinai at the State of the Science Summit™ on Multiple Myeloma discuss emerging treatment strategies
Video
Miriam Merad, MD, PhD, Advocates for the Immuno-Genomics Classification of Cancer
Dr. Merad discusses how our ability to identify the genomic variation of primary tumors can lead to novel combination therapies.
Video
Lewis R. Silverman, MD: An Overview of Myelodysplastic Syndrome and Personalized Therapies
Lewis R. Silverman, MD, one of the foremost researchers in myelodysplastic syndrome, shares insights into the disease as well as the current state of research.
Video
Augusto Villanueva, MD, PhD, Discusses New Therapies and Challenges in Liver Cancer
From Harlem to Mongolia, Dr. Villanueva reviews global trends in liver cancer and new therapies available.
Video
Latest Treatment Options From the Dubin Breast Center
A multidisciplinary team provides the latest treatment options for breast cancer
News
Dr. William Oh discusses treatment strategies for Metastatic Hormone-Sensitive Prostate Cancer
Metastatic hormone-sensitive prostate cancer (mHSPC) is deadly, with a reported median survival of less than 5 years. Historically, androgen deprivation therapy (ADT) has been the standard of care. The development of new therapeutic options, ...
Video
Genomic Landscape of Lung Adenocarcinoma
Cancer biology determines the heterogeneity of lung cancer
Video
Cancer Immunotherapy: In Search of the Other “C” Word (Cure) for Cancer Patients
Moving Cancer Immunotherapy Forward
Video
Lung Cancer Screening: Translating Science Into Improved Patient Outcomes
Evidence supports lung cancer screening
Video
Breaking Down the Barriers: Disparities in Colorectal Cancer Screening in African Americans
African Americans experience low rates of colorectal cancer screening
